|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity
Kenji Adachi
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan, adachiknj{at}chugai-pharm.co.jp, Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan
Masami Suzuki
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Tetsurou Sugimoto
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Keigo Yorozu
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Hirotake Takai
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd., Shizuoka, Japan
Koji Uetsuka
Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan
Hiroyuki Nakayama
Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan
Kunio Doi
Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan
We evaluated the effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin (BLM)-induced lung injury that developed diffuse alveolar damage and subsequent pulmonary fibrosis (PF) of varying severity. G-CSF (100 µg/kg/day) was administered subcutaneously to BLM (0.2, 20, 2,000 µg)-treated or -untreated rats for 3 or 14 days. In the BLM 0.2 µg group, slight alveolar mononuclear cell infiltration was observed, although PF was not noted. In the BLM 20-µg and 2,000-µg groups, diffuse alveolar damage along with neutrophil infiltration and subsequent PF were observed. In the saline + G-CSF group and BLM 0.2 µg + G-CSF group, a marked increase in the number of alkaline phosphatase (ALP)-positive neutrophils was noted in the alveolar capillaries, although there was neither neutrophil infiltration in alveoli nor exacerbation of lung injury. In the BLM 20 µg + G-CSF and BLM 2,000 µg + G-CSF groups, an exacerbation of lung injury along with an increase in the number of ALP-positive neutrophils in the alveoli was observed. These results indicate that the administration of G-CSF to rats with slight lung injury bearing no PF does not exacerbate the lung injury. The exacerbating effects of G-CSF seem to be associated not only with the marked infiltration of activated neutrophils but also with the severity of underlying lung injury.
Key Words: Granulocyte colony-stimulating factor bleomycin lung injury pulmonary fibrosis neutrophil alkaline phosphatase rat histopathology.
References
- Adachi K., Suzuki M., Sugimoto T., Uetsuka K., Nakayama H., Doi K. (2001). Effects of granulocyte colony-stimulating factor on the development of inflammation in bleomycin-induced lung injury. J Toxicol Pathol 14: 289—297.[CrossRef]
- Adachi K., Suzuki M., Sugimoto T., Suzuki S., Niki R., Oyama A., Uetsuka K., Nakayama H., Doi K. (2002). Granulocyte colony-stimulating factor exacerbates the acute lung injury and pulmonary fibrosis induced by intratracheal administration of bleomycin in rats. Exp Toxic Pathol 53: 501—510.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ashcroft T., Simpson JM, Timbrell V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41: 467— 470.[Abstract/Free Full Text]
- Azoulay E., Attalah H., Half A., Schlemmer B., Delclaux C. (2001). Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data. Chest 120: 1695—1701.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bastion Y., Reyes F., Bosly A., Gisselbrecht C., Yver A., Gilles E., Maral J., Coiffier B. (1994). Possible toxicity with the association of G-CSF and bleomycin. Lancet 343: 1221—1222.[Web of Science][Medline]
[Order article via Infotrieve]
- Bastion Y., Coiffier B. (1994). Pulmonary toxicity of bleomycin: is G-CSF a risk factor? Lancet 344: 474.[Web of Science][Medline]
[Order article via Infotrieve]
- Bronchud MH, Scarffe JH, Thatcher N., Crowther D., Souza LM, Alton NK, Testa NG, Dexter TM (1987). Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56: 809—813.[Web of Science][Medline]
[Order article via Infotrieve]
- Chandler DB, Hyde DM, Giri SN ( 1983). Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol 112: 170—177.[Abstract]
- Cohen AM, Zsebo KM, Inoue H., Hines D., Boone TC, Chazin VR, Tsai L., Ritch T., Souza LM (1987). In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 84: 2484—2488.[Abstract/Free Full Text]
- Demetri GD, Griffin JD (1991). Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791—2808.[Free Full Text]
- Edelson JD, Shannon JM, Mason RJ (1988). Alkalinephosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 13: 1268— 1275.
- Eisenbeis CF, Winn D., Poelman S., Polsky CV, Rubenstein JH, Olopade OI (2001). A case of pulmonary toxicity associated with G-CSF and doxorubicin administration. Ann Hematol 80: 121—123.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fukuda Y., Ishizaki M., Masuda Y., Kimura G., Kawanami O., Masugi Y. (1987). The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 126: 171—182.[Abstract]
- Gabrilove JL, Jakubowski A., Scher H., Sternberg C., Wong G., Grous J., Yagoda A., Fain K., Moore Mas, Clarkson B., Oettgen HF, Alton K., Welte K., Souza L. (1988). Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414—1422.[Abstract]
- Gabrilove JL, Jakubowski A., Fain K., Grous J., Scher H., Sternberg C., Yagoda A., Clarkson B., Bonilla MA, Oettgen HF, Alton K., Boone T., Altrock B., Welte K., Lawrence S. (1988). Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 82: 1454—1461.[Web of Science][Medline]
[Order article via Infotrieve]
- Gordon AN, Hancock KC, Matthews CM, Stringer CA, Boston J., Nemunaitis J. (1999). A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxel. Am J Clin Oncol 22: 601—605.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gordon LI, Young M., Weller E., Habermann TM, Winter JN, Glick J., Ghosh C., Flynn P., Cassileth PA (1999). A phase II trial of 200% ProMACE-CytaBOM in patients with previously untreated aggressive lymphomas: analysis of response, toxicity, and dose intensity. Blood 94: 3307—3314.[Abstract/Free Full Text]
- Harousseau JL, Witz B., Lioure B., Hunault-Berger M., Desablens B., Delain M., Guilhot F., Le Prise PY, Abgrall JF, Deconinck E., Guyotat D., Vilque JP, Casassus P., Tournilhac O., Audhuy B., Solary E. (2000). Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques. J Clin Oncol 2000 18: 780—787.[Abstract/Free Full Text]
- Iki S., Yoshinaga K., Ohbayashi Y., Urabe A. (1993). Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF—clinical attention. Ann Hematol 66: 217—218.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kanazawa M., Ishizaka A., Hasegawa N., Suzuki Y., Yokoyama T. (1992). Granulocyte colony-stimulating factor dose not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 145: 1030—1035.[Web of Science][Medline]
[Order article via Infotrieve]
- Katoh M., Shirai T., Shikoshi K., Ishii M., Kitagawa S. (1992). Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker. Eur J Hematol 49: 19—24.[Web of Science][Medline]
[Order article via Infotrieve]
- Kawamoto M., Fukuda Y. (1990). Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats. ActaPathol Jpn 40: 227—238.
- King J., Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G., Mercante DE, Summer WR, Nelson S. (1995). Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 151: 302—309.[Abstract]
- Koizumi T., Kubo K., Shinozaki S., Koyama S., Kobayashi T., Sekiguchi M. (1993). Granulocyte colony-stimulating factor dose not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 148: 132— 137.[Web of Science][Medline]
[Order article via Infotrieve]
- Koizumi T., Kubo K., Koyama S., Hanaoka M., Hayano T., Miyahara T., Kobayashi T., Sekiguchi M. (1997). Neutrophils pretreated with granulocyte colony-stimulating factor (G-CSF) are not related to the severity of endotoxin-induced lung injury. Exp Lung Res 23: 393—404.[Web of Science][Medline]
[Order article via Infotrieve]
- Lalisang RI, Wils JA, Nortier HW, Burghouts JT, Hupperets PS, Erdkamp FL, Schouten HC, Blijham GH (1997). Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer. J Clin Oncol 15: 1367—1376.[Abstract]
- Lazenby AJ, Crouch EC, McDonald JA, Kuhn III C. (1990). Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat—an immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis 142: 206—214.[Web of Science][Medline]
[Order article via Infotrieve]
- Linch DC, Milligan DW, Winfield DA, Kelsey SM, Johnson SA, Littlewood TJ, Smith GM, Hutchinson RM, Goldstone AH, Fielding AK, Vaughan Hudson G (1997). G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial. Br J Haematol 99: 933—938.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lindenschmidt RC, Tryka AF, Godfrey GA, Frome EL, Witschi H. (1986). Intratracheal versus intravenous administration of bleomycin in mice: acute effects. Toxicol Appl Pharmacol 85: 69—77.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mautz WJ, Kleinman MT, Phalen RF, Crocker TT (1988). Effects of exercise exposure on toxic interactions between inhaled oxidant and aldehyde air pollutants. J Toxicol Environ Health 25: 165—177.[Web of Science][Medline]
[Order article via Infotrieve]
- Morstyn G., Campbell L., Souza LM, Alton NK, Keech J., Green M., Sherdan W., Metcalf D. (1988). Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1: 667—671.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Niitsu N., Iki S., Muroi K., Motomura S., Murakami M., Takeyama H., Ohsaka A., Urabe A. (1997). Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991—96. Br J Cancer 76: 1661—1666.[Web of Science][Medline]
[Order article via Infotrieve]
- Pojda Z., Molineux G., Dexter TM (1990). Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp Hematol 18: 27—31.[Web of Science][Medline]
[Order article via Infotrieve]
- Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T., Relling MV, Ribeiro RC, Crist WM, Evans WE (1997). Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 336: 1781—1787.[Abstract/Free Full Text]
- Saxman SB, Nichols CR, Einhorn LH (1997). Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor. Chest 111: 657—660.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schmitz N., Linch DC, Dreger P., Goldstone AH, Boogaerts MA, Ferrant A., Demuynck HMS, Link H., Zander A., Barge A., Borkett K. (1996). Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347: 353—357.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Stein RS (1994). Clinical use of growth factors in the myelodysplastic syndromes. Am J Med Sci 307: 360—367.[Web of Science][Medline]
[Order article via Infotrieve]
- Suzuki M., Adachi K., Ogawa Y., Karasawa Y., Katsuyama K., Sugimoto T., Doi K. (2000). The combination of fixation using PLP fixative and embedding in paraffin by the AMeX method is useful for immunohistochemical and enzyme histochemical studies of the lung. J Toxicol Pathol 13: 109— 113.[CrossRef]
- Suzuki M., Katsuyama K., Adachi K., Ogawa Y., Yorozu K., Fujii E., Misawa Y., Sugimoto T. (2002). Combination of fixation using PLP fixative and embedding in paraffin by the AMeX method is useful for histochemical studies in assessment of immunotoxicity. J Toxicol Sci 27: 165—172.[CrossRef][Medline]
[Order article via Infotrieve]
- Dirix LY, Schrijvers D., Druwè P., Brande JVD, Verhoeven D., Oosterom Atv (1994). Pulmonary toxicity and bleomycin. Lancet 344: 56.[Web of Science][Medline]
[Order article via Infotrieve]
- Terashima T., Kanazawa M., Sayama K., Ishizaka A., Urano T., Sakamaki F., Nakamura H., Waki Y., Tasaka S. (1994). Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Respir Crit Care Med 149: 1295—1303.[Abstract]
- Thrall RS, McCormick JR, Jack RM, McReynolds RA, Ward PA ( 1979). Bleomycin-induced pulmonary fibrosis in the rat—inhibition by indomethacin. Am J Pathol 95: 117—130.[Abstract]
- Ulich TR, Castillo JD, Souza L. (1988). Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am J Pathol 133: 630—638.[Abstract]
- Usuki J., Fukuda Y. (1995). Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol Inter 45: 552—564.[Web of Science][Medline]
[Order article via Infotrieve]
- Watanabe K., Fishman WH (1964). Application of the stereospecific inhibitor L-phenylalanine to the enzymorphology of intestinal alkaline phosphatase. J Histochem Cytochem 12: 252—260.[Abstract]
- Welte K., Gabrilove J., Bronchud MH, Platzer E., Morstyn G. (1996). Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88: 1907—1929.[Free Full Text]
- Yokose N., Ogata K., Tamura H., An E., Nakamura K., Kamikubo K., Kudoh S., Nomura T. (1998). Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma. Br J Cancer 77: 2286—2290.[Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 31, No. 6,
665-673 (2003)
DOI: 10.1080/01926230390244924

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Sasaki, R. Kuroda, K. Ishida, S. Kubo, T. Matsumoto, Y. Mifune, K. Kinoshita, K. Tei, T. Akisue, Y. Tabata, et al.
Enhancement of Tendon-Bone Osteointegration of Anterior Cruciate Ligament Graft Using Granulocyte Colony-Stimulating Factor
Am. J. Sports Med.,
August 1, 2008;
36(8):
1519 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|